DNA
Prototype to Enterprise Traction Fast
Case Study
Overview
Client: DNA
Industry: Enterprise Technology / AI and Agentic InsurTech
Stage: Prototype → Enterprise Traction
Engagement: Operator & Strategic Advisor
DNA is an early-stage technology venture that had launched a minimum-viable product roughly a year prior to our engagement. While the technical foundation existed, the company lacked an aligned team, a disciplined execution engine, and a clear go-to-market strategy — resulting in stalled momentum despite strong underlying potential.
Challenge
Following its initial MVP launch, DNA struggled to convert build effort into market traction.
The product had been developed in fragments, without a unified execution team or shared operating rhythm. There was no clear GTM motion, limited customer discovery structure, and insufficient professional depth to move from prototype into enterprise credibility.
The core issue was not product viability — it was organizational alignment and execution readiness.
Approach
Working closely with the CEO, I was brought in to stabilize execution, upgrade talent, and build the operational spine required for enterprise traction.
Key Actions:
Conducted a strategic assessment of existing materials, product assets, and execution gaps with the founder.
Identified the need to elevate the team to the founder’s level of focus, professionalism, and execution discipline.
Recruited high-caliber young professionals from top management-consulting firms to form a sharp, aligned core team.
Trained the team using battle-tested methodologies across product development, customer discovery, and execution cadence.
Built out the go-to-market function by bringing in experienced sales and marketing specialists.
Partnered with a leading product-development studio to strengthen software engineering and technology advisory capabilities.
Supported the CEO through a rapid fundraising round as early traction emerged, securing additional working capital.
With enterprise pilots underway, collaborated with leadership and a Wall Street investment banker to design a structured, forward-looking financing strategy to fuel the next growth phase.
This approach emphasized execution discipline, talent density, and parallel progress across product, GTM, and capital — ensuring momentum was built, not borrowed.
Results
Early Quantitative & Strategic Outcomes:
Transition from fragmented build effort to aligned execution team
Clear GTM motion supporting enterprise-level conversations
Successful initiation of pilots with market-leading enterprise clients
Improved capital position through a fast, focused fundraising round
Defined financing roadmap to support scalable growth
Qualitative Outcomes:
Elevated execution standards across the organization
Stronger internal alignment between product, go-to-market, and leadership
Increased confidence from enterprise prospects and partners
Momentum restored through clarity, professionalism, and pace
Strategic Insights
Key Decision:
Recognizing that early technical progress without execution infrastructure creates false momentum — and addressing that gap decisively.
Hidden Blind Spot:
Underestimating how much team quality, operating rhythm, and GTM discipline determine whether a product earns enterprise trust.
Lessons for Others:
Talent density matters as much as technology at the transition from prototype to scale.
Execution systems must evolve in parallel with the product.
Enterprise traction requires professionalism, clarity, and consistency — not just innovation.
Conclusion
By upgrading talent, building execution discipline, and aligning product, GTM, and capital strategy, DNA moved from stalled MVP momentum toward credible enterprise traction.
The engagement demonstrated that early-stage ventures don’t fail from lack of ideas — they stall when execution maturity doesn’t keep pace with ambition. With the right structure and focus, DNA is now positioned to scale with confidence.